Long-term disease control in AD could be in reach with anti-OX40 antibody KHK4083 Presented ByProf. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA TrialPhase 2 ConferenceEADV 2021 TypePeer-reviewed article 18 November 2021 13:28